Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1057)
VERACYTE, INC. (VCYT)
Chambers Rebecca — Chief Financial Officer
Shares
1,175
Price
$43.71
Total Value
$51.36K
Shares Held After
166,025
% of Holdings
0.7%
VERACYTE, INC. (VCYT)
Chambers Rebecca — Chief Financial Officer
Shares
2,477
Price
$42.81
Total Value
$106.03K
Shares Held After
167,200
% of Holdings
1.5%
VERACYTE, INC. (VCYT)
McGuire Annie — EVP, General Counsel
Shares
1,100
Price
$43.67
Total Value
$48.04K
Shares Held After
131,160
% of Holdings
0.8%
VERACYTE, INC. (VCYT)
McGuire Annie — EVP, General Counsel
Shares
2,154
Price
$42.79
Total Value
$92.17K
Shares Held After
132,260
% of Holdings
1.6%
VERACYTE, INC. (VCYT)
Febbo Phillip G. — Chief Scientific&Med Officer
Shares
2,705
Price
$43.66
Total Value
$118.11K
Shares Held After
133,048
% of Holdings
2.0%
VERACYTE, INC. (VCYT)
Febbo Phillip G. — Chief Scientific&Med Officer
Shares
10,405
Price
$42.89
Total Value
$446.30K
Shares Held After
135,753
% of Holdings
7.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
399
Price
$366.56
Total Value
$146.26K
Shares Held After
1,302,145
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
826
Price
$365.41
Total Value
$301.83K
Shares Held After
1,302,544
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
1,329
Price
$364.48
Total Value
$484.39K
Shares Held After
1,303,370
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
565
Price
$363.34
Total Value
$205.29K
Shares Held After
1,304,699
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
1,992
Price
$362.65
Total Value
$722.40K
Shares Held After
1,305,264
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
1,242
Price
$361.61
Total Value
$449.12K
Shares Held After
1,307,256
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
2,320
Price
$360.47
Total Value
$836.28K
Shares Held After
1,308,498
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
3,392
Price
$359.39
Total Value
$1.22M
Shares Held After
1,310,818
% of Holdings
0.3%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
3,180
Price
$358.42
Total Value
$1.14M
Shares Held After
1,314,210
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
3,962
Price
$357.57
Total Value
$1.42M
Shares Held After
1,317,390
% of Holdings
0.3%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
3,267
Price
$356.37
Total Value
$1.16M
Shares Held After
1,321,352
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
2,006
Price
$355.57
Total Value
$713.28K
Shares Held After
1,324,619
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
520
Price
$354.54
Total Value
$184.36K
Shares Held After
1,326,625
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
405
Price
$366.56
Total Value
$148.46K
Shares Held After
1,347,543
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
847
Price
$365.42
Total Value
$309.51K
Shares Held After
1,347,948
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
1,358
Price
$364.48
Total Value
$494.96K
Shares Held After
1,348,795
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
573
Price
$363.34
Total Value
$208.20K
Shares Held After
1,350,153
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
2,010
Price
$362.65
Total Value
$728.93K
Shares Held After
1,350,726
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
1,214
Price
$361.61
Total Value
$438.99K
Shares Held After
1,352,736
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
2,266
Price
$360.46
Total Value
$816.81K
Shares Held After
1,353,950
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
3,357
Price
$359.39
Total Value
$1.21M
Shares Held After
1,356,216
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
3,143
Price
$358.42
Total Value
$1.13M
Shares Held After
1,359,573
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
3,981
Price
$357.57
Total Value
$1.42M
Shares Held After
1,362,716
% of Holdings
0.3%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
3,297
Price
$356.37
Total Value
$1.17M
Shares Held After
1,366,697
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
2,029
Price
$355.57
Total Value
$721.46K
Shares Held After
1,369,994
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
520
Price
$354.54
Total Value
$184.36K
Shares Held After
1,372,023
% of Holdings
0.0%
Atara Biotherapeutics, Inc. (ATRA)
Cherry Brian N — Director
Shares
104,166
Price
$9.60
Total Value
$999.99K
Shares Held After
166,486
% of Holdings
62.6%
Kymera Therapeutics, Inc. (KYMR)
Adams Brian — Chief Legal Officer
Shares
2,137
Price
$117.57
Total Value
$251.25K
Shares Held After
50,254
% of Holdings
4.1%
Kymera Therapeutics, Inc. (KYMR)
Adams Brian — Chief Legal Officer
Shares
3,025
Price
$116.81
Total Value
$353.35K
Shares Held After
52,391
% of Holdings
5.5%
Kymera Therapeutics, Inc. (KYMR)
Adams Brian — Chief Legal Officer
Shares
1,209
Price
$115.55
Total Value
$139.70K
Shares Held After
55,416
% of Holdings
2.1%
Alector, Inc. (ALEC)
Wong-Sarad Grace — Principal Accounting Officer
Shares
3,625
Price
$2.51
Total Value
$9.09K
Shares Held After
106,015
% of Holdings
3.3%
Caris Life Sciences, Inc. (CAI)
Spetzler David Baxley — President
Shares
119,212
Price
$24.76
Total Value
$2.95M
Shares Held After
1,182,871
% of Holdings
9.2%
Definium Therapeutics, Inc. (DFTX)
Barrow Robert — Director
Shares
19,023
Price
$37.94
Total Value
$721.73K
Shares Held After
1,494,640
% of Holdings
1.3%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
800
Price
$1.09
Total Value
$872.00
Shares Held After
381,985
% of Holdings
0.2%
Alector, Inc. (ALEC)
Rosenthal Arnon — Director
Shares
72,606
Price
$2.66
Total Value
$193.47K
Shares Held After
2,294,600
% of Holdings
3.1%
Alector, Inc. (ALEC)
Wong-Sarad Grace — Principal Accounting Officer
Shares
5,165
Price
$2.67
Total Value
$13.77K
Shares Held After
109,640
% of Holdings
4.5%
Alector, Inc. (ALEC)
Berkley Neil Lindsay — CFO&Chief Business Officer
Shares
29,251
Price
$2.66
Total Value
$77.95K
Shares Held After
350,649
% of Holdings
7.7%
Caris Life Sciences, Inc. (CAI)
Spetzler David Baxley — President
Shares
84,900
Price
$25.32
Total Value
$2.15M
Shares Held After
1,052,083
% of Holdings
7.5%
Caris Life Sciences, Inc. (CAI)
Spetzler David Baxley — President
Shares
393,100
Price
$24.76
Total Value
$9.73M
Shares Held After
1,136,983
% of Holdings
25.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
42
Price
$491.25
Total Value
$20.63K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
940
Price
$490.50
Total Value
$461.07K
Shares Held After
324,485
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,114
Price
$489.62
Total Value
$1.52M
Shares Held After
325,425
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,604
Price
$488.68
Total Value
$783.85K
Shares Held After
328,539
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,429
Price
$487.87
Total Value
$697.16K
Shares Held After
330,143
% of Holdings
0.4%
Showing 1–50 of 1057 transactions (page 1 of 22)